Cargando…

Signal transduction inhibitors in treatment of myelodysplastic syndromes

Myelodysplastic syndromes (MDS) are a group of hematologic disorders characterized by ineffective hematopoiesis that results in reduced blood counts. Although MDS can transform into leukemia, most of the morbidity experienced by these patients is due to chronically low blood counts. Conventional cyt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bachegowda, Lohith, Gligich, Oleg, Mantzaris, Ionnis, Schinke, Carolina, Wyville, Dale, Carrillo, Tatiana, Braunschweig, Ira, Steidl, Ulrich, Verma, Amit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3716523/ https://www.ncbi.nlm.nih.gov/pubmed/23841999 http://dx.doi.org/10.1186/1756-8722-6-50

Ejemplares similares

Granuloma Annulare
por: Gupta, Diptesh, et al.
Publicado: (2010)

Linked-In: Design and Efficacy of Antibody Drug Conjugates in Oncology
por: Feld, Jonathan, et al.
Publicado: (2013)

Myelodysplastic Syndrome Progression to Acute Myeloid Leukemia at the Stem Cell Level
por: Chen, Jiahao, et al.
Publicado: (2018)

Case report of combination therapy with Azacytidine, Enasidenib and Venetoclax in primary refractory AML
por: Jasra, Sakshi, et al.
Publicado: (2021)

Analysis of overall survival in a large multiethnic cohort reveals absolute neutrophil count of 1,100 as a novel prognostic cutoff in African Americans
por: Mantzaris, Ioannis, et al.
Publicado: (2016)

Clinical and Molecular Insights in Erythropoiesis Regulation of Signal Transduction Pathways in Myelodysplastic Syndromes and β-Thalassemia
por: Parisi, Sarah, et al.
Publicado: (2021)

Elevated LDH greater than 400 U/L portends poorer overall survival in diffuse large B-cell lymphoma patients treated with CD19 CAR-T cell therapy in a real world multi-ethnic cohort
por: Rabinovich, Emma, et al.
Publicado: (2021)

Sinusoidal Obstruction Syndrome (SOS) in Multiple Myeloma with Renal Failure
por: Shah, Urvi A., et al.
Publicado: (2018)

Professor Balfour of Edinburgh
por: Thomson, C. Wyville
Publicado: (1878)

Inhibitors of Brassinosteroid Biosynthesis and Signal Transduction
por: Rozhon, Wilfried, et al.
Publicado: (2019)

Adult T-cell leukemia/lymphoma in the Caribbean cohort is a distinct clinical entity with dismal response to conventional chemotherapy
por: Zell, Monica, et al.
Publicado: (2016)

Signal transduction inhibitors for the treatment of rheumatoid arthritis
por: Tanaka, Yoshiya, et al.
Publicado: (2012)

Signal Transduction Inhibitors as Promising Anticancer Agents
por: Kumar, Raj, et al.
Publicado: (2015)

String dualities and the Geroch group
por: Bakas, Ionnis
Publicado: (1994)

Special Issue “Signal Transductions in Fungi”
por: Kück, Ulrich
Publicado: (2022)

IL1RAP potentiates multiple oncogenic signaling pathways in AML
por: Mitchell, Kelly, et al.
Publicado: (2018)

Activation of targetable inflammatory immune signaling is seen in myelodysplastic syndromes with SF3B1 mutations
por: Choudhary, Gaurav S, et al.
Publicado: (2022)

Rigosertib as a selective anti-tumor agent can ameliorate multiple dysregulated signaling transduction pathways in high-grade myelodysplastic syndrome
por: Xu, Feng, et al.
Publicado: (2014)

On integrable models from pp-wave string backgrounds
por: Bakas, Ionnis, et al.
Publicado: (2002)

Myelodysplastic Syndrome and Histone Deacetylase Inhibitors: “To Be or Not to Be Acetylated”?
por: Stintzing, Sebastian, et al.
Publicado: (2011)

Signal transduction
por: Gomperts, B. D.
Publicado: (2002)

P524: PHARMACODYNAMICALLY DEFINED METRONOMIC DOSING OF DECITABINE AND VENETOCLAX IN ACUTE MYELOID LEUKEMIA
por: Fedorov, Kateryna, et al.
Publicado: (2023)

MiST: a microbial signal transduction database
por: Ulrich, Luke E., et al.
Publicado: (2007)

Cellular Signal Transductions and Their Inhibitors Derived from Deep-Sea Organisms
por: Wang, Liyan, et al.
Publicado: (2021)

The Rising Era of Immune Checkpoint Inhibitors in Myelodysplastic Syndromes
por: Chokr, Nora, et al.
Publicado: (2018)

Prognostic Markers of Myelodysplastic Syndromes
por: Veryaskina, Yuliya Andreevna, et al.
Publicado: (2020)

JAK2 V617F mutation, multiple hematologic and non-hematologic processes: an association?
por: Liu, Kenneth G., et al.
Publicado: (2016)

Neurospora crassa Light Signal Transduction Is Affected by ROS
por: Belozerskaya, Tatiana A., et al.
Publicado: (2012)

Epidemiologic study of myelodysplastic syndromes in a multiethnic, inner city cohort
por: Sridharan, Ashwin, et al.
Publicado: (2014)

Integrin signal transduction
por: Leslie, Mitch
Publicado: (2006)

Signal transduction in T lymphocytes
por: Cantrell, D
Publicado: (2005)

Artificial Signal Transduction
por: Bekus, Robert, et al.
Publicado: (2020)

Mitochondrial signal transduction
por: Picard, Martin, et al.
Publicado: (2022)

Glutaminase inhibition in combination with azacytidine in myelodysplastic syndromes: Clinical efficacy and correlative analyses
por: Konopleva, Marina, et al.
Publicado: (2023)

Signal transduction and signaling networks
por: Ikeda, Fumiyo, et al.
Publicado: (2013)

Use of radiolabelled choline as a pharmacodynamic marker for the signal transduction inhibitor geldanamycin
por: Liu, D, et al.
Publicado: (2002)

Proteomic identification of secreted proteins as surrogate markers for signal transduction inhibitor activity
por: McClelland, C M, et al.
Publicado: (2007)

Reversal of Bortezomib Resistance in Myelodysplastic Syndrome Cells by MAPK Inhibitors
por: Yue, Yingxing, et al.
Publicado: (2014)

A cat with myelodysplastic syndrome by administration of the methylation inhibitor Azacytidine
por: HISASUE, Masaharu, et al.
Publicado: (2021)

Assessing the Prognosis of Patients with Myelodysplastic Syndromes (MDS)
por: Kasprzak, Annika, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pvop8b7ubi1san25vqd1gj708a